Literature DB >> 7830542

Experimental evaluation of small intestinal submucosa as a microvascular graft material.

C D Prevel1, B L Eppley, M McCarty, J R Jackson, S L Voytik, M C Hiles, S F Badylak.   

Abstract

The evaluation of porcine small intestine submucosa (SIS) in a microsurgical model was conducted using an interpositional graft in the rat femoral artery. The SIS grafts were fabricated from processed porcine material that was wrapped around a glass tube and oversewn longitudinally to produce a tubular structure. Of the 42 animals studied, 7 received grafts of untreated SIS (group I), 7 of the grafts were presoaked (PSH) in heparin (Group II), 7 animals were treated with systemic heparin prior to implantation of PSH-SIS (group III), 7 animals received SIS grafts crosslinked to heparin (group IV), 7 animals received SIS grafts crosslinked to urokinase (group V), and 7 animals received untreated autologous epigastric vein grafts (group VI). Patency was assessed postoperatively and selected grafts were evaluated by histology. All SIS grafts failed to maintain patency beyond the first postoperative hour. Histologic examination of the thrombosed graft surfaces revealed a smooth luminal surface with a thick layer of attached fibrin and platelets with a central occluding thrombus. The thickness of the induced fibrin layer appears to narrow intraluminal space significantly at the microvascular level. While having excellent success at vessel diameters greater than 3 mm, and in a variety of nonporcine animal models without xenographic rejection, SIS in this model was thrombogenic despite a favorable surface morphology as demonstrated by SEM. Even with use of heparin and urokinase SIS graft thrombosis occurred.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7830542     DOI: 10.1002/micr.1920150812

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  6 in total

1.  Comparison of small-intestinal submucosa and expanded polytetrafluoroethylene as a vascular conduit in the presence of gram-positive contamination.

Authors:  Daniel H Shell; Martin A Croce; Catherine Cagiannos; T Wright Jernigan; Norma Edwards; Timothy C Fabian
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

2.  Development and Characterization of Acellular Extracellular Matrix Scaffolds from Porcine Menisci for Use in Cartilage Tissue Engineering.

Authors:  Ying-Chen Chen; Ray-Neng Chen; Hua-Jing Jhan; Der-Zen Liu; Hsiu-O Ho; Yong Mao; Joachim Kohn; Ming-Thau Sheu
Journal:  Tissue Eng Part C Methods       Date:  2015-06-10       Impact factor: 3.056

3.  Successful endothelialization and remodeling of a cell-free small-diameter arterial graft in a large animal model.

Authors:  Maxwell T Koobatian; Sindhu Row; Randall J Smith; Carmon Koenigsknecht; Stelios T Andreadis; Daniel D Swartz
Journal:  Biomaterials       Date:  2015-10-14       Impact factor: 12.479

4.  Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery.

Authors:  Wei Wu; Robert A Allen; Yadong Wang
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

5.  Poly(ethylmethacrylate-co-diethylaminoethyl acrylate) coating improves endothelial re-population, bio-mechanical and anti-thrombogenic properties of decellularized carotid arteries for blood vessel replacement.

Authors:  Elena López-Ruiz; Seshasailam Venkateswaran; Macarena Perán; Gema Jiménez; Salvatore Pernagallo; Juan J Díaz-Mochón; Olga Tura-Ceide; Francisco Arrebola; Juan Melchor; Juan Soto; Guillermo Rus; Pedro J Real; María Diaz-Ricart; Antonio Conde-González; Mark Bradley; Juan A Marchal
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 6.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.